Search Results - "O'Brien, Bernie J"

Cost-effectiveness acceptability curves - facts, fallacies and frequently asked questions by Fenwick, Elisabeth, O'Brien, Bernie J., Briggs, Andrew

“…Cost‐effectiveness acceptability curves (CEACs) have been widely adopted as a method to quantify and graphically represent uncertainty in economic evaluation…”
Get full text

Quality of life in the Canadian Implantable Defibrillator Study (CIDS) by Irvine, Jane, Dorian, Paul, Baker, Brian, O'Brien, Bernie J., Roberts, Robin, Gent, Michael, Newman, David, Connolly, Stuart J.

“…Background The primary aim of this study was to compare quality-of-life outcome between patients randomized to implantable cardioverter defibrillator (ICD)…”
Get full text

Cost-effectiveness of Rhythm versus Rate control in Atrial fibrillation by MARSHALL, Deborah A, LEVY, Adrian R, VIDAILLET, Humberto, FENWICK, Elisabeth, SLEE, April, BLACKHOUSE, Gordon, GREENE, H. Leon, WYSE, D. George, NICHOL, Graham, OBRIEN, Bernie J

“…Atrial fibrillation is the most common type of sustained cardiac arrhythmia, but recent trials have identified no clear advantage of rhythm control over rate…”
Get full text

Cost-effectiveness of the Implantable cardioverter-defibrillator : Results from the Canadian Implantable Defibrillator Study (CIDS) by O'BRIEN, Bernie J, CONNOLLY, Stuart J, GOEREE, Ron, BLACKHOUSE, Gordon, WILLAN, Andrew, YEE, Raymond, ROBERTS, Robin S, GENT, Michael

“…In the Canadian Implantable Defibrillator Study (CIDS), we assessed the cost-effectiveness of the implantable cardioverter-defibrillator (ICD) in reducing the…”
Get full text

Effect of clinical risk stratification on cost-effectiveness of the Implantable cardioverter-defibrillator: The Canadian Implantable Defibrillator Study by SHELDON, Robert, O'BRIEN, Bernie J, BLACKHOUSE, Gordon, GOEREE, Ron, MITCHELL, Brent, KLEIN, George, ROBERTS, Robin S, GENT, Michael, CONNOLLY, Stuart J

“…Three randomized clinical trials showed that implantable cardioverter-defibrillators (ICDs) reduce the risk of death in survivors of ventricular…”
Get full text

Confidence intervals for cost-effectiveness ratios: An application of Fieller's theorem by Willan, Andrew R., O'Brien, Bernie J.

“…Application of cost‐effectiveness analysis (CEA) is growing rapidly in health care. Two general approaches to analysis are differentiated by the type of data…”
Get full text

Oseltamivir for Treatment of Influenza in Healthy Adults: Pooled Trial Evidence and Cost-Effectiveness Model for Canada by O'Brien, Bernie J., Goeree, Ron, Blackhouse, Gordon, Smieja, Marek, Loeb, Mark

“…Influenza is a common viral respiratory infection that is associated with significant morbidity. Oseltamivir (Tamiflu) is a neuraminidase inhibitor—a new class…”
Get full text

Cost-Effectiveness Analysis of Predischarge Monitoring for Apnea of Prematurity by Zupancic, John A. F, Richardson, Douglas K, O'Brien, Bernie J, Eichenwald, Eric C, Weinstein, Milton C

“…It is standard practice to defer discharge of premature infants until they have achieved a set number of days without experiencing apnea. The duration of this…”
Get full text

Thinking outside the box: recent advances in the analysis and presentation of uncertainty in cost-effectiveness studies by Briggs, Andrew H, O'Brien, Bernie J, Blackhouse, Gordon

“…As many more clinical trials collect economic information within their study design, so health economics analysts are increasingly working with patient-level…”
Get full text

Cost-effectiveness of β-blocker therapy with metoprolol or with carvedilol for treatment of heart failure in Canada by Levy, Adrian R., Briggs, Andrew H., Demers, Catherine, O’Brien, Bernie J.

“…Objective The purpose of this study was to estimate the cost-effectiveness of β-blocker therapy with either metoprolol or carvedilol in addition to…”
Get full text

Economic considerations for health insurance coverage of emerging genetic tests by Giacomini, Mita, Miller, Fiona, O'Brien, Bernie J

“…Public and private health insurance plans face the question of whether to cover emerging genetic tests for cancer and other diseases. This paper outlines…”
Get more information

Economics and priority setting by O'Brien, Bernie J

Get full text

Probabilistic analysis of cost-effectiveness models: choosing between treatment strategies for gastroesophageal reflux disease by Briggs, Andrew H, Goeree, Ron, Blackhouse, Gord, O'Brien, Bernie J

“…When choosing between mutually exclusive treatment options, it is common to construct a cost-effectiveness frontier on the cost-effectiveness plane that…”
Get full text

The death of cost-minimization analysis? by Briggs, Andrew H., O'Brien, Bernie J.

“…Four different types of evaluation methods, cost‐benefit analysis (CBA), cost‐utility analysis (CUA), cost‐effectiveness analysis (CEA) and cost‐minimization…”
Get full text

Systematic Implementation of an Advance Directive Program in Nursing Homes: A Randomized Controlled Trial by Molloy, D. William, Guyatt, Gordon H, Russo, Rosalie, Goeree, Ron, O'Brien, Bernie J, Bédard, Michel, Willan, Andy, Watson, Jan, Patterson, Christine, Harrison, Christine, Standish, Tim, Strang, David, Darzins, Peteris J, Smith, Stephanie, Dubois, Sacha

“…CONTEXT Although advance directives are commonly used in the community, little is known about the effects of their systematic implementation. OBJECTIVES To…”
Get full text

Cost-effective prescribing: trying to hit the target in Ontario and Australia by Bernie J. O'Brien

“…The Canadian province of Ontario does not subsidise prescription drugs for all of its citizens. Despite serving fewer beneficiaries, the Ontario system is…”
Get full text

Advances in risk-benefit evaluation using probabilistic simulation methods: an application to the prophylaxis of deep vein thrombosis by Lynd, Larry D., O'Brien, Bernie J.

“…To demonstrate the use of probabilistic simulation modeling to estimate the joint density of therapeutic risks and benefits. Published data are used to…”
Get full text

Analysis of a pharmaceutical risk sharing agreement based on the purchaser's total budget by Zaric, Gregory S., O'Brien, Bernie J.

“…Many public and private healthcare payers use formularies as a tool for controlling drug costs and quality. Although the price per dose is often negotiated as…”
Get full text

Is there a kink in consumers' threshold value for cost-effectiveness in health care? by O'Brien, Bernie J., Gertsen, Kirsten, Willan, Andrew R., Faulkner, A.

“…Background: A reproducible observation is that consumers' willingness‐to‐accept (WTA) monetary compensation to forgo a program is greater than their stated…”
Get full text

Cost effectiveness of the prevention and treatment of deep vein thrombosis and pulmonary embolism by Anderson, D R, O'Brien, B J

“…The purpose of this article is to review and critically appraise the cost-effectiveness analyses that have compared various modalities for the prevention and…”
Get full text